First Horizon Advisors’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$6.16K Hold
2025
Q1
$5.16K Hold
2024
Q4
$5.17K Hold
2024
Q3
$5.23K Hold
2024
Q2
$4.25K Hold
2024
Q1
$3.5K Hold
2023
Q4
$4.12K Hold
2023
Q3
$4.87K Hold
2023
Q2
$4.84K Hold
2023
Q1
$5.74K Buy
2022
Q4
$3.96K Hold
2022
Q3
$4K Buy